- Home
- STRM vs RLYB Comparison
STRM vs RLYB Comparison
Compare STRM & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRM
- RLYB
- Stock Information
- Founded
- STRM 1989
- RLYB 2018
- Country
- STRM United States
- RLYB United States
- Employees
- STRM N/A
- RLYB N/A
- Industry
- STRM EDP Services
- RLYB Biotechnology: Pharmaceutical Preparations
- Sector
- STRM Technology
- RLYB Health Care
- Exchange
- STRM Nasdaq
- RLYB Nasdaq
- Market Cap
- STRM 15.4M
- RLYB 13.3M
- IPO Year
- STRM 1996
- RLYB 2021
- Fundamental
- Price
- STRM $2.59
- RLYB $0.29
- Analyst Decision
- STRM
- RLYB Hold
- Analyst Count
- STRM 0
- RLYB 4
- Target Price
- STRM N/A
- RLYB $15.00
- AVG Volume (30 Days)
- STRM 5.9K
- RLYB 86.0K
- Earning Date
- STRM 06-10-2025
- RLYB 05-08-2025
- Dividend Yield
- STRM N/A
- RLYB N/A
- EPS Growth
- STRM N/A
- RLYB N/A
- EPS
- STRM N/A
- RLYB N/A
- Revenue
- STRM $17,901,000.00
- RLYB $848,000.00
- Revenue This Year
- STRM $18.64
- RLYB N/A
- Revenue Next Year
- STRM N/A
- RLYB N/A
- P/E Ratio
- STRM N/A
- RLYB N/A
- Revenue Growth
- STRM N/A
- RLYB N/A
- 52 Week Low
- STRM $1.82
- RLYB $0.22
- 52 Week High
- STRM $9.75
- RLYB $2.00
- Technical
- Relative Strength Index (RSI)
- STRM 44.37
- RLYB 35.98
- Support Level
- STRM $2.30
- RLYB $0.29
- Resistance Level
- STRM $3.40
- RLYB $0.33
- Average True Range (ATR)
- STRM 0.27
- RLYB 0.02
- MACD
- STRM 0.01
- RLYB 0.02
- Stochastic Oscillator
- STRM 32.32
- RLYB 42.19
About STRM Streamline Health Solutions Inc.
Streamline Health Solutions Inc provides transformational data-driven solutions for healthcare organizations. It provides computer software-based solutions through its looking glass platform. Its solutions include coding and CDI, coding audit, and financial management solutions. It offers various services, such as custom integration services, training services, electronic image conversion and database monitoring services. It sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.